Email Alert RSS
Volume 14 Issue 2
Mar.  2023
Turn off MathJax
Article Contents
Abstract
References
Related Articles
ZHOU Yu, SONG Hongmei. Interpretation on the 2021 EULAR/American College of Rheumatology Points to Consider for Diagnosis, Management and Monitoring of the Interleukin-1 Mediated Autoinflammatory Diseases: Cryopyrin-Associated Periodic Syndromes, Tumour Necrosis Factor Receptor-Associated Periodic Syndrome, Mevalonate Kinase Deficiency, and Deficiency of the Interleukin-1 Receptor Antagonist[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(2): 271-277. DOI: 10.12290/xhyxzz.2023-0043
Citation: ZHOU Yu, SONG Hongmei. Interpretation on the 2021 EULAR/American College of Rheumatology Points to Consider for Diagnosis, Management and Monitoring of the Interleukin-1 Mediated Autoinflammatory Diseases: Cryopyrin-Associated Periodic Syndromes, Tumour Necrosis Factor Receptor-Associated Periodic Syndrome, Mevalonate Kinase Deficiency, and Deficiency of the Interleukin-1 Receptor Antagonist[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(2): 271-277. DOI: 10.12290/xhyxzz.2023-0043
shu

Interpretation on the 2021 EULAR/American College of Rheumatology Points to Consider for Diagnosis, Management and Monitoring of the Interleukin-1 Mediated Autoinflammatory Diseases: Cryopyrin-Associated Periodic Syndromes, Tumour Necrosis Factor Receptor-Associated Periodic Syndrome, Mevalonate Kinase Deficiency, and Deficiency of the Interleukin-1 Receptor Antagonist

  • Department of Pediatrics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

Funds: 

National Key Research and Development Program of China 2021YFC2702001

National High Level Hospital Clinical Research Funding 2022-PUMCH-B-079

Beijing Natural Science Foundation L202050

More Information
  • Corresponding author:

    SONG Hongmei, E-mail: songhm1021@126.com

  • Received Date: January 17, 2023
  • Accepted Date: January 30, 2023
  • Available Online: February 09, 2023
  • Issue Publish Date: March 29, 2023
    Graphical Abstract
    • Abstract
  • Interleukin-1 mediated autoinflammatory diseases, a large class of autoinflammatory diseases characterized by increased release of interleukin-1 or activation of the interleukin-1 pathway, mainly include familial Mediterranean fever, cryopyrin-associated periodic syndrome, tumor necrosis factor receptor associated periodic syndrome, mevalonate kinase deficiency syndrome and deficiency of the interleukin-1 receptor antagonist. These diseases present in early childhood and affect multiple systems, which, if untreated, may result in progressive organ damage, morbidity and mortality. In 2016, European Alliance of Associations for Rheumatology (EULAR) published recommendations for familial Mediterranean fever. For the latter four types of diseases, EULAR and the American College of Rheumatology developed several points in terms of diagnosis, management and monitoring in 2022. This article aims to introduce the application of these points.
    • FullText(HTML)
    • References (38)
  • [1]
    Masters SL, Simon A, Aksentijevich I, et al. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*)[J]. Annu Rev Immunol, 2009, 27: 621-68. DOI: 10.1146/annurev.immunol.25.022106.141627
    [2]
    Ahmadi N, Brewer CC, Zalewski C, et al. Cryopyrin-associated periodic syndromes: otolaryngologic and audiologic manifestations[J]. Otolaryngol Head Neck Surg, 2011, 145: 295-302. DOI: 10.1177/0194599811402296
    [3]
    Dollfus H, Hafner R, Hofmann HM, et al. Chronic infantile neurological cutaneous and articular/neonatal onset multisystem inflammatory disease syndrome: ocular manifestations in a recently recognized chronic inflammatory disease of childhood[J]. Arch Ophthalmol, 2000, 118: 1386-1392. DOI: 10.1001/archopht.118.10.1386
    [4]
    Hill SC, Namde M, Dwyer A, et al. Arthropathy of neonatal onset multisystem inflammatory disease (NOMID/CINCA)[J]. Pediatr Radiol, 2007, 37: 145-152. DOI: 10.1007/s00247-006-0358-0
    [5]
    Lane T, Loeffler JM, Rowczenio DM, et al. AA amyloidosis complicating the hereditary periodic fever syndromes[J]. Arthritis Rheum, 2013, 65: 1116-1121. DOI: 10.1002/art.37827
    [6]
    Levy R, Gerard L, Kuemmerle-Deschner J, et al. Pheno-typic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever Registry[J]. Ann Rheum Dis, 2015, 74: 2043-2049.
    [7]
    Lachmann HJ, Papa R, Gerhold K, et al. The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry[J]. Ann Rheum Dis, 2014, 73: 2160-2167. DOI: 10.1136/annrheumdis-2013-204184
    [8]
    Ozen S, Demirkaya E, Erer B, et al. EULAR recommendations for the management of familial Mediterranean fever[J]. Ann Rheum Dis, 2016, 75: 644-651. DOI: 10.1136/annrheumdis-2015-208690
    [9]
    Romano M, Arici ZS, Piskin D, et al. The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist[J]. Ann Rheum Dis, 2022, 81: 907-921. DOI: 10.1136/annrheumdis-2021-221801
    [10]
    Romano M, Arici ZS, Piskin D, et al. The 2021 EULAR/American College of Rheumatology Points to Consider for Diagnosis, Management and Monitoring of the Interleukin-1 Mediated Autoinflammatory Diseases: Cryopyrin-Associated Periodic Syndromes, Tumour Necrosis Factor Receptor-Associated Periodic Syndrome, Mevalonate Kinase Deficiency, and Deficiency of the Interleukin-1 Receptor Antagonist[J]. Arthritis Rheumatol, 2022, 74: 1102-1121. DOI: 10.1002/art.42139
    [11]
    Kuemmerle-Deschner JB, Ozen S, Tyrrell PN, et al. Diagnostic criteria for cryopyrin-associated periodic syndrome (CAPS)[J]. Ann Rheum Dis, 2017, 76: 942-947. DOI: 10.1136/annrheumdis-2016-209686
    [12]
    Zhou Y, Wang W, Zhong L, et al. Clinical and genetic spectrum of 14 cases of NLRP3-associated autoinflammatory disease (NLRP3-AID) in China and a review of the literature[J]. Orphanet J Rare Dis, 2022, 17: 214. DOI: 10.1186/s13023-022-02364-z
    [13]
    Sobolewska B, Angermair E, Deuter C, et al. NLRP3 A439V Mutation in a Large Family with Cryopyrin-associated Periodic Syndrome: Description of Ophthalmologic Symptoms in Correlation with Other Organ Symptoms[J]. J Rheumatol, 2016, 43: 1101-1106. DOI: 10.3899/jrheum.150681
    [14]
    Kilic H, Sahin S, Duman C, et al. Spectrum of the neurologic manifestations in childhood-onset cryopyrin-associated periodic syndrome[J]. Eur J Paediatr Neurol, 2019, 23: 466-472. DOI: 10.1016/j.ejpn.2019.03.006
    [15]
    Li C, Tan X, Zhang J, et al. Gene mutations and clinical phenotypes in 15 Chinese children with cryopyrin-associated periodic syndrome (CAPS)[J]. Sci China Life Sci, 2017, 60: 1436-1444. DOI: 10.1007/s11427-017-9246-4
    [16]
    Livneh A, Drenth JP, Klasen IS, et al. Familial Mediterranean fever and hyperimmunoglobulinemia D syndrome: two diseases with distinct clinical, serologic, and genetic features[J]. J Rheumatol, 1997, 24: 1558-1563.
    [17]
    van der Hilst JCH, Bodar EJ, Barron KS, et al. Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome[J]. Medicine (Baltimore), 2008, 87: 301-310. DOI: 10.1097/MD.0b013e318190cfb7
    [18]
    Jeyaratnam J, Ter Haar NM, de Sain-van der Velden MG, et al. Diagnostic Value of Urinary Mevalonic Acid Excretion in Patients with a Clinical Suspicion of Mevalonate Kinase Deficiency (MKD)[J]. JIMD Rep, 2016, 27: 33-38.
    [19]
    Garg M, de Jesus AA, Chapelle D, et al. Rilonacept maintains long-term inflammatory remission in patients with deficiency of the IL-1 receptor antagonist[J]. JCI Insight, 2017, 2: e94838. DOI: 10.1172/jci.insight.94838
    [20]
    Feldmann J, Prieur AM, Quartier P, et al. Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes[J]. Am J Hum Genet, 2002, 71: 198-203. DOI: 10.1086/341357
    [21]
    Mcdermott MF, Aksentijevich I, Galon J, et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes[J]. Cell, 1999, 97: 133-144. DOI: 10.1016/S0092-8674(00)80721-7
    [22]
    D'osualdo A, Picco P, Caroli F, et al. MVK mutations and associated clinical features in Italian patients affected with autoinflammatory disorders and recurrent fever[J]. Eur J Hum Genet, 2005, 13: 314-320. DOI: 10.1038/sj.ejhg.5201323
    [23]
    Aksentijevich I, Masters SL, Ferguson PJ, et al. An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist[J]. N Engl J Med, 2009, 360: 2426-2437. DOI: 10.1056/NEJMoa0807865
    [24]
    Rowczenio DM, Gomes SM, Arostegui JI, et al. Late-Onset Cryopyrin-Associated Periodic Syndromes Caused by Somatic NLRP3 Mosaicism-UK Single Center Experience[J]. Front Immunol, 2017, 8: 1410. DOI: 10.3389/fimmu.2017.01410
    [25]
    Sibley CH, Plass N, Snow J, et al. Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anak-inra: a cohort study to determine three- and five-year outcomes[J]. Arthritis Rheum, 2012, 64: 2375-2386. DOI: 10.1002/art.34409
    [26]
    Hoffman HM, Throne ML, Amar NJ, et al. Long-term efficacy and safety profile of rilonacept in the treatment of cryopryin-associated periodic syndromes: results of a 72-week open-label extension study[J]. Clin Ther, 2012, 34: 2091-2103. DOI: 10.1016/j.clinthera.2012.09.009
    [27]
    Brogan PA, Hofer M, Kuemmerle-Deschner JB, et al. Rapid and Sustained Long-Term Efficacy and Safety of Canakinumab in Patients With Cryopyrin-Associated Periodic Syndrome Ages Five Years and Younger[J]. Arthritis Rheumatol, 2019, 71: 1955-1963. DOI: 10.1002/art.41004
    [28]
    Piram M, Kone-Paut I, Lachmann HJ, et al. Validation of the auto-inflammatory diseases activity index (AIDAI) for hereditary recurrent fever syndromes[J]. Ann Rheum Dis, 2014, 73: 2168-2173. DOI: 10.1136/annrheumdis-2013-203666
    [29]
    Batchelor HK, Marriott JF. Paediatric pharmacokinetics: key considerations[J]. Br J Clin Pharmacol, 2015, 79: 395-404. DOI: 10.1111/bcp.12267
    [30]
    Bodar EJ, Kuijk LM, Drenth JP, et al. On-demand anakinra treatment is effective in mevalonate kinase deficiency[J]. Ann Rheum Dis, 2011, 70: 2155-2158. DOI: 10.1136/ard.2011.149922
    [31]
    Grimwood C, Despert V, Jeru I, et al. On-demand treatment with anakinra: a treatment option for selected TRAPS patients[J]. Rheumatology (Oxford), 2015, 54: 1749-1751. DOI: 10.1093/rheumatology/kev111
    [32]
    Rodriguez-Smith J, Lin YC, Tsai WL, et al. Cerebrospinal Fluid Cytokines Correlate With Aseptic Meningitis and Blood-Brain Barrier Function in Neonatal-Onset Multisystem Inflammatory Disease: Central Nervous System Biomarkers in Neonatal-Onset Multisystem Inflammatory Disease Correlate With Central Nervous System Inflammation[J]. Arthritis Rheumatol, 2017, 69: 1325-1336. DOI: 10.1002/art.40055
    [33]
    Kuemmerle-Deschner JB, Welzel T, Hoertnagel K, et al. New variant in the IL1RN-gene (DIRA) associated with late-onset, CRMO-like presentation[J]. Rheumatology (Oxford), 2020, 59: 3259-3263. DOI: 10.1093/rheumatology/keaa119
    [34]
    Papa R, Lane T, Minden K, et al. INSAID Variant Classification and Eurofever Criteria Guide Optimal Treatment Strategy in Patients with TRAPS: Data from the Eurofever Registry[J]. J Allergy Clin Immunol Pract, 2021, 9: 783-991. e4. DOI: 10.1016/j.jaip.2020.10.053
    [35]
    Ozen S, Kuemmerle-Deschner JB, Cimaz R, et al. International Retrospective Chart Review of Treatment Patterns in Severe Familial Mediterranean Fever, Tumor Necrosis Factor Receptor-Associated Periodic Syndrome, and Mevalonate Kinase Deficiency/Hyperimmunoglobulinemia D Syndrome[J]. Arthritis Care Res (Hoboken), 2017, 69: 578-586. DOI: 10.1002/acr.23120
    [36]
    Obici L, Meini A, Cattalini M, et al. Favourable and sustained response to anakinra in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) with or without AA amyloidosis[J]. Ann Rheum Dis, 2011, 70: 1511-1512. DOI: 10.1136/ard.2010.143438
    [37]
    Ter Haar NM, Jeyaratnam J, Lachmann HJ, et al. The Phenotype and Genotype of Mevalonate Kinase Deficiency: A Series of 114 Cases From the Eurofever Registry[J]. Arthritis Rheumatol, 2016, 68: 2795-2805. DOI: 10.1002/art.39763
    [38]
    de Benedetti F, Gattorno M, Anton J, et al. Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes[J]. N Engl J Med, 2018, 378: 1908-1919. DOI: 10.1056/NEJMoa1706314
    • Related Articles

  • Related Articles

    [1]ZHAO Qin, WANG Haiying, WANG Hui, ZHANG Jinjin, XING Yanchao. Plateau Refractory Wounds Treated with Platelet Lysate Gel: A Case Report[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(6): 1408-1412. DOI: 10.12290/xhyxzz.2024-0195
    [2]LUO Hanhuan, SHI Jie, BIANBA Zhaxi, YANG Xu, NIMA Zhuoma, WANG Qian, LI Mei, WANG Han, LIAO Ruiqian, CIREN Quzhen. Expression of H3K27me3 in Tibetan Patients with Gastric Cancer and Its Significance[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(6): 1088-1093. DOI: 10.12290/xhyxzz.2021-0727
    [3]LIU Yuan, ZHAO Lin. Update and Interpretation of 2022 National Comprehensive Cancer Network Clinical Practice Guidelines for Gastric Cancer[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(6): 999-1004. DOI: 10.12290/xhyxzz.2022-0271
    [4]LUO Hanhuan, WANG Qian, DA Zhen, DUOBU La, CIREN Quzhen, HUO Zhen. Analysis of Disease Spectrum of Testicular and Adnexal Lesions in Tibetan Population of Tibet[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(4): 687-692. DOI: 10.12290/xhyxzz.2021-0349
    [5]GAO Zhongshan, REN Ming, MA Yulan, ZHU Lulu. Polymorphism of Gut Microbiota in High Altitude Tibetan Patients with Coronary Artery Heart Disease[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(2): 332-340. DOI: 10.12290/xhyxzz.2021-0652
    [6]LI Xirong. Multi-modal Deep Learning and Its Applications in Ophthalmic Artificial Intelligence[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(5): 602-607. DOI: 10.12290/xhyxzz.2021-0500
    [7]CIDAN Wangjiu, LABA Dunzhu, WANG Fengdan, GU Xiao, CHEN Shi, LIU Yongliang, SHI Lei, PAN Hui, YIN Wu, JIN Zhengyu. Comparison of Three Methods of Assessing the Bone Age in Tibetan Children and the Features of Their Skeletal Maturity[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(3): 411-416. DOI: 10.12290/xhyxzz.20200259
    [8]Li-ming XIA, Jian SHEN, Rong-guo ZHANG, Shao-kang WANG, Kuan CHEN. Application of Deep Learning in Medical Imaging Research[J]. Medical Journal of Peking Union Medical College Hospital, 2018, 9(1): 10-14. DOI: 10.3969/j.issn.1674-9081.2018.01.003
    [9]Tao XU, Shao-mei HAN, Guang-jin ZHU, Jun-ting LIU. Comparison of Body Composition between Tibetan and Han Adolescents[J]. Medical Journal of Peking Union Medical College Hospital, 2016, 7(2): 110-114. DOI: 10.3969/j.issn.1674-9081.2016.02.006

  • Cited by

    Periodical cited type(4)

    1. 贾棋茹. 孟鲁司特钠治疗活动性肺结核的疗效及对患者生活质量的影响. 医师在线. 2025(01): 11-14 .
    2. 马锡慧，李彬钰，韩永，孔祥瑞，孙玉洁，郭宗伟，郭欣鑫，崔文哲，肖漓. 结核病患者外周血淋巴细胞亚群以及12项血浆细胞因子流式检测分析. 中华检验医学杂志. 2024(07): 755-762 .
    3. 杨晨晨，如克亚木·阿不都沙拉木，徐茜. 肺结核患者外周血T细胞协同刺激分子表达和NK细胞比例. 细胞与分子免疫学杂志. 2024(07): 629-635 .
    4. 陈志祥，艾克拜尔，陈存存，车勇. 结核T细胞斑点试验联合外周血T淋巴细胞亚群检测在临床诊断中的价值. 贵州医药. 2024(11): 1683-1686 .

    Other cited types(2)

Catalog

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (3025) PDF downloads (149) Cited by(6)
    Related
    Links: National Health Commission of the People's Republic of China Chinese Academy of Medical Sciences(CAMS) AMLC Check CNKI Database CNKI Term Online Chinese General Practice
    Address：Room 302,Third Floor,Building 7, No. 1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing 100730, China
    Tel：010-69154261/4262
    E - mail：medj@pumch.cn mjpumch@126.com
    Copyright of website：Editorial Office of Medical Journal of Peking Union Medical College Hospital

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close